NCT01167075 (Intestamin) is a NA clinical trial of Fresubin Original in Critical Illness, sponsored by Hannover Medical School.

Who is sponsoring NCT01167075?

NCT01167075 is sponsored by Hannover Medical School.

What drugs are being tested in NCT01167075?

Interventions in NCT01167075: Fresubin Original, Intestamin plus Fresubin Original.

What condition does NCT01167075 study?

NCT01167075 studies Critical Illness, Adult, Sepsis, Systemic Inflammatory Response Syndrome.

Is NCT01167075 still recruiting?

NCT01167075 is currently completed. Last updated 21 July 2010.

Last reviewed 2010-07-21 · How we verify

NCT01167075: Intestamin

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized, Prospective, Controlled, Double-blind, Single-center Pilot Study in Critically Ill Patients Investigating Tolerability and Efficacy of Low-volume Pharmaconutrition (Intestamin)

Completed NA Last updated 21 July 2010

What this trial tests

NA trial testing Fresubin Original in Critical Illness in 58 participants. Completed in 1 February 2009.

Timeline

1 February 2006

Primary endpoint
1 February 2009

1 February 2009

Quick facts

Lead sponsor	Hannover Medical School
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	58
Start date	1 February 2006
Primary completion	1 February 2009
Estimated completion	1 February 2009
Sites	1 location across Germany

Drugs / interventions tested

Fresubin Original
Intestamin plus Fresubin Original

Conditions studied

Critical Illness — all drugs for Critical Illness →
Adult — all drugs for Adult →
Sepsis — all drugs for Sepsis →
Systemic Inflammatory Response Syndrome — all drugs for Systemic Inflammatory Response Syndrome →

Sponsor

Hannover Medical School

Who can join

Adults 18 to 75, any sex, with Critical Illness or Adult. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Length of stay in ICU
Time frame: 14 days
The primary endpoints were length of stay in ICU and sufficient enteral feed.

Sponsor's own description

The aim of the study is to assess the efficacy and tolerability of the low-volume supplement. The investigators randomized critically ill patients to receive Intestamin plus Fresubin or Fresubin alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting

Other Hannover Medical School trials

Trials by the same sponsor.

NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
NCT06795516 — Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation · terminated
NCT06603311 — Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of · NA · active not recruiting
NCT06493006 — Promoting Sustainable and Active Mobility Among Employees and Students · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01167075 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hannover Medical School
Last refreshed: 21 July 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01167075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing